 | • レポートコード：MRC2012A7567 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、一次抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。一次抗体の種類別市場規模（ポリクローナル、モノクローナル）、用途別市場規模（ELISA、ウエスタンブロット、免疫染色、免疫組織化学、免疫細胞化学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abcam、MBL、Sigma Aldrich Corporation、BD、R&D Systems、Santa Cruz Biotechnology、Merk、Bio-Rad、Thermo Fisher Scientific、CST、MABTech、Novus Biologicals、KPL、AbMax Biotechnology、PeproTech、Abnova、Cayman、 ・地域別グローバル市場分析 2015年-2020年 ・一次抗体の北米市場（アメリカ、カナダ、メキシコ） ・一次抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・一次抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・一次抗体の南米市場（ブラジル、アルゼンチン） ・一次抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ポリクローナル、モノクローナル ・用途別分析：ELISA、ウエスタンブロット、免疫染色、免疫組織化学、免疫細胞化学、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Primary Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Primary Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Primary Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Primary Antibodies market has been segmented into
Polyclonal
Monoclonal
By Application, Primary Antibodies has been segmented into:
ELISA
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Primary Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level Primary Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Primary Antibodies market.
The report offers in-depth assessment of the growth and other aspects of the Primary Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Primary Antibodies Market Share Analysis
Primary Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Primary Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Primary Antibodies sales, revenue and market share for each player covered in this report.
The major players covered in Primary Antibodies are:
Abcam
MBL
Sigma Aldrich Corporation
BD
R&D Systems
Santa Cruz Biotechnology
Merk
Bio-Rad
Thermo Fisher Scientific
CST
MABTech
Novus Biologicals
KPL
AbMax Biotechnology
PeproTech
Abnova
Cayman
Among other players domestic and global, Primary Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Primary Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Primary Antibodies, with price, sales, revenue and global market share of Primary Antibodies in 2018 and 2019.
Chapter 3, the Primary Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Primary Antibodies market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Primary Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Primary Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Primary Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market Analysis by Application
1.3.1 Overview: Global Primary Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 ELISA
1.3.3 Western Blot
1.3.4 Immunostaining
1.3.5 Immunohistochemistry
1.3.6 Immunocytochemistry
1.3.7 Other
1.4 Overview of Global Primary Antibodies Market
1.4.1 Global Primary Antibodies Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abcam
2.1.1 Abcam Details
2.1.2 Abcam Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abcam SWOT Analysis
2.1.4 Abcam Product and Services
2.1.5 Abcam Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MBL
2.2.1 MBL Details
2.2.2 MBL Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MBL SWOT Analysis
2.2.4 MBL Product and Services
2.2.5 MBL Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sigma Aldrich Corporation
2.3.1 Sigma Aldrich Corporation Details
2.3.2 Sigma Aldrich Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sigma Aldrich Corporation SWOT Analysis
2.3.4 Sigma Aldrich Corporation Product and Services
2.3.5 Sigma Aldrich Corporation Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 R&D Systems
2.5.1 R&D Systems Details
2.5.2 R&D Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 R&D Systems SWOT Analysis
2.5.4 R&D Systems Product and Services
2.5.5 R&D Systems Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Santa Cruz Biotechnology
2.6.1 Santa Cruz Biotechnology Details
2.6.2 Santa Cruz Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Santa Cruz Biotechnology SWOT Analysis
2.6.4 Santa Cruz Biotechnology Product and Services
2.6.5 Santa Cruz Biotechnology Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merk
2.7.1 Merk Details
2.7.2 Merk Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merk SWOT Analysis
2.7.4 Merk Product and Services
2.7.5 Merk Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio-Rad SWOT Analysis
2.8.4 Bio-Rad Product and Services
2.8.5 Bio-Rad Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific SWOT Analysis
2.9.4 Thermo Fisher Scientific Product and Services
2.9.5 Thermo Fisher Scientific Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 CST
2.10.1 CST Details
2.10.2 CST Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 CST SWOT Analysis
2.10.4 CST Product and Services
2.10.5 CST Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 MABTech
2.11.1 MABTech Details
2.11.2 MABTech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 MABTech SWOT Analysis
2.11.4 MABTech Product and Services
2.11.5 MABTech Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Novus Biologicals
2.12.1 Novus Biologicals Details
2.12.2 Novus Biologicals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Novus Biologicals SWOT Analysis
2.12.4 Novus Biologicals Product and Services
2.12.5 Novus Biologicals Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 KPL
2.13.1 KPL Details
2.13.2 KPL Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 KPL SWOT Analysis
2.13.4 KPL Product and Services
2.13.5 KPL Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 AbMax Biotechnology
2.14.1 AbMax Biotechnology Details
2.14.2 AbMax Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 AbMax Biotechnology SWOT Analysis
2.14.4 AbMax Biotechnology Product and Services
2.14.5 AbMax Biotechnology Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 PeproTech
2.15.1 PeproTech Details
2.15.2 PeproTech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 PeproTech SWOT Analysis
2.15.4 PeproTech Product and Services
2.15.5 PeproTech Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Abnova
2.16.1 Abnova Details
2.16.2 Abnova Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Abnova SWOT Analysis
2.16.4 Abnova Product and Services
2.16.5 Abnova Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Cayman
2.17.1 Cayman Details
2.17.2 Cayman Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Cayman SWOT Analysis
2.17.4 Cayman Product and Services
2.17.5 Cayman Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Primary Antibodies Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Primary Antibodies Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Primary Antibodies Manufacturer Market Share in 2019
3.3.2 Top 6 Primary Antibodies Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Primary Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Primary Antibodies Sales and Market Share by Regions (2015-2020)
4.1.2 Global Primary Antibodies Revenue and Market Share by Regions (2015-2020)
4.2 North America Primary Antibodies Sales and Growth Rate (2015-2020)
4.3 Europe Primary Antibodies Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Primary Antibodies Sales and Growth Rate (2015-2020)
4.5 South America Primary Antibodies Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Primary Antibodies Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Primary Antibodies Sales, Revenue and Market Share by Country
5.1.1 North America Primary Antibodies Sales and Market Share by Country (2015-2020)
5.1.2 North America Primary Antibodies Revenue and Market Share by Country (2015-2020)
5.2 United States Primary Antibodies Sales and Growth Rate (2015-2020)
5.3 Canada Primary Antibodies Sales and Growth Rate (2015-2020)
5.4 Mexico Primary Antibodies Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Primary Antibodies Sales, Revenue and Market Share by Country
6.1.1 Europe Primary Antibodies Sales and Market Share by Country (2015-2020)
6.1.2 Europe Primary Antibodies Revenue and Market Share by Country (2015-2020)
6.2 Germany Primary Antibodies Sales and Growth Rate (2015-2020)
6.3 UK Primary Antibodies Sales and Growth Rate (2015-2020)
6.4 France Primary Antibodies Sales and Growth Rate (2015-2020)
6.5 Russia Primary Antibodies Sales and Growth Rate (2015-2020)
6.6 Italy Primary Antibodies Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Primary Antibodies Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Primary Antibodies Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Primary Antibodies Revenue and Market Share by Regions (2015-2020)
7.2 China Primary Antibodies Sales and Growth Rate (2015-2020)
7.3 Japan Primary Antibodies Sales and Growth Rate (2015-2020)
7.4 Korea Primary Antibodies Sales and Growth Rate (2015-2020)
7.5 India Primary Antibodies Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Primary Antibodies Sales and Growth Rate (2015-2020)
7.7 Australia Primary Antibodies Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Primary Antibodies Sales, Revenue and Market Share by Country
8.1.1 South America Primary Antibodies Sales and Market Share by Country (2015-2020)
8.1.2 South America Primary Antibodies Revenue and Market Share by Country (2015-2020)
8.2 Brazil Primary Antibodies Sales and Growth Rate (2015-2020)
8.3 Argentina Primary Antibodies Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Primary Antibodies Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Primary Antibodies Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Primary Antibodies Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Primary Antibodies Sales and Growth Rate (2015-2020)
9.3 Turkey Primary Antibodies Sales and Growth Rate (2015-2020)
9.4 Egypt Primary Antibodies Sales and Growth Rate (2015-2020)
9.5 South Africa Primary Antibodies Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Primary Antibodies Sales and Market Share by Type (2015-2020)
10.2 Global Primary Antibodies Revenue and Market Share by Type (2015-2020)
10.3 Global Primary Antibodies Price by Type (2015-2020)
11 Global Primary Antibodies Market Segment by Application
11.1 Global Primary Antibodies Sales Market Share by Application (2015-2020)
11.2 Global Primary Antibodies Revenue Market Share by Application (2015-2020)
11.3 Global Primary Antibodies Price by Application (2015-2020)
12 Market Forecast
12.1 Global Primary Antibodies Sales, Revenue and Growth Rate (2021-2025)
12.2 Primary Antibodies Market Forecast by Regions (2021-2025)
12.2.1 North America Primary Antibodies Market Forecast (2021-2025)
12.2.2 Europe Primary Antibodies Market Forecast (2021-2025)
12.2.3 Asia-Pacific Primary Antibodies Market Forecast (2021-2025)
12.2.4 South America Primary Antibodies Market Forecast (2021-2025)
12.2.5 Middle East & Africa Primary Antibodies Market Forecast (2021-2025)
12.3 Primary Antibodies Market Forecast by Type (2021-2025)
12.3.1 Global Primary Antibodies Sales Forecast by Type (2021-2025)
12.3.2 Global Primary Antibodies Market Share Forecast by Type (2021-2025)
12.4 Primary Antibodies Market Forecast by Application (2021-2025)
12.4.1 Global Primary Antibodies Sales Forecast by Application (2021-2025)
12.4.2 Global Primary Antibodies Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Primary Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Primary Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Primary Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abcam Basic Information, Manufacturing Base and Competitors
Table 8. Abcam Primary Antibodies Major Business
Table 9. Abcam Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 10. Abcam SWOT Analysis
Table 11. Abcam Primary Antibodies Product and Services
Table 12. Abcam Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MBL Basic Information, Manufacturing Base and Competitors
Table 14. MBL Primary Antibodies Major Business
Table 15. MBL Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 16. MBL SWOT Analysis
Table 17. MBL Primary Antibodies Product and Services
Table 18. MBL Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sigma Aldrich Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Sigma Aldrich Corporation Primary Antibodies Major Business
Table 21. Sigma Aldrich Corporation Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 22. Sigma Aldrich Corporation SWOT Analysis
Table 23. Sigma Aldrich Corporation Primary Antibodies Product and Services
Table 24. Sigma Aldrich Corporation Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BD Basic Information, Manufacturing Base and Competitors
Table 26. BD Primary Antibodies Major Business
Table 27. BD Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 28. BD SWOT Analysis
Table 29. BD Primary Antibodies Product and Services
Table 30. BD Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 32. R&D Systems Primary Antibodies Major Business
Table 33. R&D Systems Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 34. R&D Systems SWOT Analysis
Table 35. R&D Systems Primary Antibodies Product and Services
Table 36. R&D Systems Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 38. Santa Cruz Biotechnology Primary Antibodies Major Business
Table 39. Santa Cruz Biotechnology Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 40. Santa Cruz Biotechnology SWOT Analysis
Table 41. Santa Cruz Biotechnology Primary Antibodies Product and Services
Table 42. Santa Cruz Biotechnology Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merk Basic Information, Manufacturing Base and Competitors
Table 44. Merk Primary Antibodies Major Business
Table 45. Merk Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 46. Merk SWOT Analysis
Table 47. Merk Primary Antibodies Product and Services
Table 48. Merk Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 50. Bio-Rad Primary Antibodies Major Business
Table 51. Bio-Rad Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 52. Bio-Rad SWOT Analysis
Table 53. Bio-Rad Primary Antibodies Product and Services
Table 54. Bio-Rad Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 56. Thermo Fisher Scientific Primary Antibodies Major Business
Table 57. Thermo Fisher Scientific Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 58. Thermo Fisher Scientific SWOT Analysis
Table 59. Thermo Fisher Scientific Primary Antibodies Product and Services
Table 60. Thermo Fisher Scientific Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. CST Basic Information, Manufacturing Base and Competitors
Table 62. CST Primary Antibodies Major Business
Table 63. CST Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 64. CST SWOT Analysis
Table 65. CST Primary Antibodies Product and Services
Table 66. CST Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. MABTech Basic Information, Manufacturing Base and Competitors
Table 68. MABTech Primary Antibodies Major Business
Table 69. MABTech Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 70. MABTech SWOT Analysis
Table 71. MABTech Primary Antibodies Product and Services
Table 72. MABTech Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 74. Novus Biologicals Primary Antibodies Major Business
Table 75. Novus Biologicals Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 76. Novus Biologicals SWOT Analysis
Table 77. Novus Biologicals Primary Antibodies Product and Services
Table 78. Novus Biologicals Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. KPL Basic Information, Manufacturing Base and Competitors
Table 80. KPL Primary Antibodies Major Business
Table 81. KPL Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 82. KPL SWOT Analysis
Table 83. KPL Primary Antibodies Product and Services
Table 84. KPL Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. AbMax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. AbMax Biotechnology Primary Antibodies Major Business
Table 87. AbMax Biotechnology Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 88. AbMax Biotechnology SWOT Analysis
Table 89. AbMax Biotechnology Primary Antibodies Product and Services
Table 90. AbMax Biotechnology Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. PeproTech Basic Information, Manufacturing Base and Competitors
Table 92. PeproTech Primary Antibodies Major Business
Table 93. PeproTech Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 94. PeproTech SWOT Analysis
Table 95. PeproTech Primary Antibodies Product and Services
Table 96. PeproTech Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Abnova Basic Information, Manufacturing Base and Competitors
Table 98. Abnova Primary Antibodies Major Business
Table 99. Abnova Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 100. Abnova SWOT Analysis
Table 101. Abnova Primary Antibodies Product and Services
Table 102. Abnova Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Cayman Basic Information, Manufacturing Base and Competitors
Table 104. Cayman Primary Antibodies Major Business
Table 105. Cayman Primary Antibodies Total Revenue (USD Million) (2017-2018)
Table 106. Cayman SWOT Analysis
Table 107. Cayman Primary Antibodies Product and Services
Table 108. Cayman Primary Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Primary Antibodies Sales by Manufacturer (2018-2019) (K MT)
Table 110. Global Primary Antibodies Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Primary Antibodies Sales by Regions (2015-2020) (K MT)
Table 112. Global Primary Antibodies Sales Market Share by Regions (2015-2020)
Table 113. Global Primary Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Primary Antibodies Sales by Countries (2015-2020) (K MT)
Table 115. North America Primary Antibodies Sales Market Share by Countries (2015-2020)
Table 116. North America Primary Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Primary Antibodies Revenue Market Share by Countries (2015-2020)
Table 118. Europe Primary Antibodies Sales by Countries (2015-2020) (K MT)
Table 119. Europe Primary Antibodies Sales Market Share by Countries (2015-2020)
Table 120. Europe Primary Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Primary Antibodies Sales by Regions (2015-2020) (K MT)
Table 122. Asia-Pacific Primary Antibodies Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Primary Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Primary Antibodies Sales by Countries (2015-2020) (K MT)
Table 125. South America Primary Antibodies Sales Market Share by Countries (2015-2020)
Table 126. South America Primary Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Primary Antibodies Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Primary Antibodies Sales by Countries (2015-2020) (K MT)
Table 129. Middle East & Africa Primary Antibodies Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Primary Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Primary Antibodies Revenue Market Share by Countries (2015-2020)
Table 132. Global Primary Antibodies Sales by Type (2015-2020) (K MT)
Table 133. Global Primary Antibodies Sales Share by Type (2015-2020)
Table 134. Global Primary Antibodies Revenue by Type (2015-2020) (USD Million)
Table 135. Global Primary Antibodies Revenue Share by Type (2015-2020)
Table 136. Global Primary Antibodies Sales by Application (2015-2020) (K MT)
Table 137. Global Primary Antibodies Sales Share by Application (2015-2020)
Table 138. Global Primary Antibodies Sales Forecast by Regions (2021-2025) (K MT)
Table 139. Global Primary Antibodies Market Share Forecast by Regions (2021-2025)
Table 140. Global Primary Antibodies Sales Forecast by Type (2021-2025) (K MT)
Table 141. Global Primary Antibodies Market Share Forecast by Type (2021-2025)
Table 142. Global Primary Antibodies Sales Forecast by Application (2021-2025)
Table 143. Global Primary Antibodies Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Primary Antibodies Picture
Figure 2. Global Sales Market Share of Primary Antibodies by Type in 2019
Figure 3. Polyclonal Picture
Figure 4. Monoclonal Picture
Figure 5. Primary Antibodies Sales Market Share by Application in 2018
Figure 6. ELISA Picture
Figure 7. Western Blot Picture
Figure 8. Immunostaining Picture
Figure 9. Immunohistochemistry Picture
Figure 10. Immunocytochemistry Picture
Figure 11. Other Picture
Figure 12. Global Primary Antibodies Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Primary Antibodies Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Primary Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Primary Antibodies Sales Market Share by Manufacturer in 2019
Figure 33. Global Primary Antibodies Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Primary Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Primary Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Primary Antibodies Revenue Market Share by Regions (2015-2020)
Figure 40. Global Primary Antibodies Revenue Market Share by Regions in 2018
Figure 41. North America Primary Antibodies Sales and Growth Rate (2015-2020)
Figure 42. Europe Primary Antibodies Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Primary Antibodies Sales and Growth Rate (2015-2020)
Figure 44. South America Primary Antibodies Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Primary Antibodies Sales and Growth Rate (2015-2020)
Figure 46. North America Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Primary Antibodies Sales Market Share by Countries (2015-2020)
Figure 48. North America Primary Antibodies Sales Market Share by Countries in 2018
Figure 49. North America Primary Antibodies Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Primary Antibodies Revenue Market Share by Countries in 2018
Figure 51. United States Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Primary Antibodies Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Primary Antibodies Revenue Market Share by Countries in 2019
Figure 57. Germany Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Primary Antibodies Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Primary Antibodies Revenue Market Share by Regions 2019
Figure 65. China Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Primary Antibodies Sales Market Share by Countries in 2019
Figure 72. South America Primary Antibodies Revenue Market Share by Countries in 2019
Figure 73. Brazil Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Primary Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Primary Antibodies Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Primary Antibodies Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Primary Antibodies Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Primary Antibodies Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Primary Antibodies Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Primary Antibodies Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Primary Antibodies Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Primary Antibodies Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Primary Antibodies Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Primary Antibodies Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Primary Antibodies Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- IGYポリクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The IGY Polyclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 診断用特殊抗体の世界市場（～2026年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 20750 million by 2026, from US$ 20090 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Diagnostic Specialty Antibodies Scope and Ma…
- 癌治療用モノクローナル抗体の世界市場（～2026年） The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 乳癌モノクローナル抗体の世界市場（～2026年） Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…